Komei Washino

Title: Komei Washino: Innovator in Radiation Protection and Tumor Affinity Peptides

Introduction

Komei Washino is a notable inventor based in Ichihara, Japan. He has made significant contributions to the field of medical technology, particularly in the development of radiation-protecting agents and tumor affinity peptides. With a total of 5 patents to his name, Washino's work is paving the way for advancements in radiopharmaceuticals.

Latest Patents

One of Washino's latest patents is a radiation-protecting agent designed to safeguard the active ingredients of radiopharmaceuticals from radiolysis. This innovative agent prevents the decomposition of reactive active ingredients while maintaining high physiological acceptability. The agent is characterized by its ability to protect radiolabeled active ingredients against radiation, with specific reaction rate constants that ensure its effectiveness. Another significant patent involves a tumor affinity peptide that has a high yield for radioactive metal labeling. This peptide is particularly useful for imaging and treating various cancers, including breast, ovarian, and colon cancer, while minimizing metabolism in normal tissues.

Career Highlights

Komei Washino is currently associated with Nihon Medi-Physics Company, Limited, where he continues to innovate in the field of medical technology. His work has garnered attention for its potential to improve diagnostic and therapeutic techniques in oncology.

Collaborations

Washino collaborates with esteemed colleagues such as Miki Kurami and Nobuo Ueda, contributing to a dynamic research environment that fosters innovation and development in medical applications.

Conclusion

Komei Washino's contributions to the field of radiopharmaceuticals and tumor affinity peptides highlight his role as a leading inventor in medical technology. His innovative patents are set to make a significant impact on cancer treatment and diagnostics.